Lv5
878 积分 2022-08-30 加入
Meta‐analysis of clinically available pharmacotherapy of biopsy confirmed metabolic dysfunction associated steatohepatitis ( MASH )
3天前
已完结
Efficacy and safety of aldafermin for the treatment of metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis
26天前
已完结
Early Real‐World Implementation of Once‐Weekly Insulin Icodec in Type 2 Diabetes
1个月前
已完结
Vascular Effects of Insulin and Their Relation to Endothelial Dysfunction, Insulin Resistance and Hypertension
2个月前
已完结
A review of survodutide: a new dual acting agonist
3个月前
已关闭
IcoSema: unveiling the future of diabetes management from a clinical pharmacology perspective
6个月前
已完结
IcoSema and the evolution of fixed-ratio insulin–GLP-1 receptor agonist therapies
6个月前
已完结
Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysis
6个月前
已完结
Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies
7个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
7个月前
已完结
皖公网安备34019202002308
